Use of Norplant implants in a New York City clinic population.
Two-hundred-eight women attending family planning clinics in New York City who received the Norplant contraceptive system during the first sixteen months of Norplant implants insertions were evaluated. Within this clinic population, Norplant implants were a popular contraceptive choice and were removed from 64 of the 208 recipients. Reasons for removal included bleeding, weight gain, and headache, and were consistent with those found in the clinical trials. Prior satisfaction with oral contraceptives did not predict success or failure with Norplant implants. The rate of follow-up visits to the family planning clinics was low. However, evidence exists that these women did not lose contact with the medical center and continued to receive health care.
Gerber
S
S
College of Physicians and Surgeons, Columbia University, New York, NY.
Westhoff
C
C
Lopez
M
M
Gordon
L
L
D000328:Adult; D003271:Contraceptive Agents, Female; D004343:Drug Implants; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage* / Q000009:adverse effects; D009519:New York City; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000139:chemically induced; D015430:Weight Gain
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D016912:Levonorgestrel